-
Jul 1999
MHC-peptide ligand interactions establish a functional threshold for antigen-specific T cell recognition.
Hum ImmunolReichstetter S, Kwok WW, Kochik S, Koelle DM, Beaty JS, Nepom GT -
Apr 1999
Radioimmunoassay for glutamic acid decarboxylase-65.
Diabetes Technol TherHao W, Daniels T, Pipeleers DG, Smismans A, Reijonen H, Nepom GT, Lernmark A -
Mar 1999
Cellular and molecular characterization of the scurfy mouse mutant.
J ImmunolClark LB, Appleby MW, Brunkow ME, Wilkinson JE, Ziegler SF, Ramsdell F -
Jan 1999
Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism.
J ImmunolLevin SD, Koelling RM, Friend SL, Isaksen DE, Ziegler SF, Perlmutter RM, Farr AG -
Jan 1999
Impaired binding of a DQ2 and DQ8-binding HSV VP16 peptide to a DQA1*0501/DQB1*0302 trans class II heterodimer.
Tissue AntigensReichstetter S, Kwok WW, Nepom GT -
Dec 1998
Exceptional stability of the HLA-DQA1*0102/DQB1*0602 alpha beta protein dimer, the class II MHC molecule associated with protection from insulin-dependent diabetes mellitus.
J ImmunolEttinger RA, Liu AW, Nepom GT, Kwok WW -
Dec 1998
Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency.
Nat GenetPuel A, Ziegler SF, Buckley RH, Leonard WJ -
Oct 1998
Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
J ImmunolDoherty DG, Penzotti JE, Koelle DM, Kwok WW, Lybrand TP, Masewicz S, Nepom GT -
Sep 1998
Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions.
J VirolKoelle DM, Frank JM, Johnson ML, Kwok WW -
Aug 1998
Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells.
J Clin InvestHershberg RM, Cho DH, Youakim A, Bradley MB, Lee JS, Framson PE, Nepom GT -
Aug 1998
Molecular basis for HLA-DQ associations with IDDM.
DiabetesNepom GT, Kwok WW -
Jul 1998
Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes.
J ImmunolBourdette DN, Chou YK, Whitham RH, Buckner JH, Kwon HJ, Nepom GT, Buenafe A, Cooper SA, Allegretta M, Hashim GA, Offner H, Vandenbark AA -
May 1998
Novel glycosylation of HLA-DRalpha disrupts antigen presentation without altering endosomal localization.
J ImmunolGuerra CB, Busch R, Doebele RC, Liu W, Sawada T, Kwok WW, Chang MD, Mellins ED -
Apr 1998
HLA-DRB1 typing in rheumatoid arthritis: predicting response to specific treatments.
Ann Rheum DisO'Dell JR, Nepom BS, Haire C, Gersuk VH, Gaur L, Moore GF, Drymalski W, Palmer W, Eckhoff PJ, Klassen LW, Wees S, Thiele G, Nepom GT -
Mar 1998
Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype.
Hum ImmunolOu D, Mitchell LA, Décarie D, Tingle AJ, Nepom GT
